Bullish Case: CBOE's launch of innovative indices like Dispersion Index and Credit VIX, strategic enhancements, new leadership appointments and increased share repurchases signal growth and operational momentum [Yahoo, Hedge Week, tradersmagazine.com, PR News Wire].


Show historical bullish cases

Bearish Case: Zeroth percentile implied volatility suggests a subdued market outlook [Helium], while insider trading reported in the past raises credibility concerns and could impede expansion initiatives, affecting stock performance [Helium].


Show historical bearish cases

Takeaway: CBOE's aggressive product innovations and leadership restructuring project potential growth, but investor vigilance is needed amidst low market volatility and past insider trading concerns [Yahoo, Hedge Week, tradersmagazine.com, Helium, Helium].


Show historical takeaways

Potential Outcomes:

1. 50%: Continued product innovation like Dispersion Index and Credit VIX might boost trader volumes and revenues [Yahoo, benzinga.com].

2. 45%: Leadership reshuffles positively impact CBOE's operational effectiveness, attracting investor confidence [Hedge Week, tradersmagazine.com].

3. 35%: Low implied volatility limits trading activity, harming profits [Helium].

4. 30%: Past insider sells lower market confidence, leading to stock depreciation [Helium]. Reasoning and Context: Continued indexing practices could bring more traders to the market [Yahoo, benzinga.com]. New leadership might drive operational improvements [Hedge Week, tradersmagazine.com]. However, lower market volatility [Helium] and insider trading [Helium] may raise concerns.


November 14, 2023


Cboe Global Markets Forecast

[CBOE]  Cboe Global Markets
Price Forecast: BULLISH    Price Action: RANDOM (?)



Make More Profitable Trades with CBOE Forecasts + Trading Strategies







CBOE Balanced News:


















Correlated Stock Forecasts

Assets that tend to move strongly with CBOE



GPOR Forecast + Options Trading Strategies   [GPOR]  Gulfport Energy (0.92)


CBAY Forecast + Options Trading Strategies   [CBAY]  Cymabay Therapeutics (0.91)


CANE Forecast + Options Trading Strategies   [CANE]  Teucrium Sugar (0.91)


DKNG Forecast + Options Trading Strategies   [DKNG]  DraftKings (0.89)


LIN Forecast + Options Trading Strategies   [LIN]  Linde (0.89)



Uncorrelated Stock Forecasts

Assets with little price relationship to CBOE



SF Forecast + Options Trading Strategies   [SF]  Stifel Financial (0.0)


CB Forecast + Options Trading Strategies   [CB]  Chubb (0.01)


LSCC Forecast + Options Trading Strategies   [LSCC]  Lattice Semiconductor (0.01)


UGL Forecast + Options Trading Strategies   [UGL]  ProShares Ultra Gold (0.01)


VO Forecast + Options Trading Strategies   [VO]  Vanguard Group, Inc. - Vanguard Mid-Cap (0.01)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against CBOE



NVCR Forecast + Options Trading Strategies   [NVCR]  NovoCure (-0.9)


INVZ Forecast + Options Trading Strategies   [INVZ]  Innoviz (-0.9)


AA Forecast + Options Trading Strategies   [AA]  Alcoa (-0.92)


ATNM Forecast + Options Trading Strategies   [ATNM]  Actinium Pharmaceuticals (-0.93)


MRNA Forecast + Options Trading Strategies   [MRNA]  Moderna (-0.93)